Back to CVR overview

Chicago Rivet & Machine Co. (CVR): A Small Rivet Maker Confronts Its Own Survival

Published September 5, 202616 min read·TickerFile Research · Chicago Rivet & Machine Co. (CVR)
ShareXLinkedIn

Chicago Rivet & Machine Co. enters the second half of 2026 as one of the smallest publicly traded industrial fasteners names in the United States, with a single-digit-million revenue base and a freshly restated going-concern qualification that places the entire equity story under a one-year solvency clock. The investment case has stopped being about growth and started being about whether the company can finance its way to a cyclical recovery without diluting or selling the parent. Two segments define the operating reality.

A fastener business whose second-quarter sales slipped modestly year over year while generating a fresh operating loss. An assembly-equipment business whose second-quarter sales rose while printing nearly the entirety of consolidated segment profit. The thesis rests on three observable drivers that compound rather than compete. First, working capital is shrinking fast, with current assets well above current liabilities but cash and equivalents of only about $0.77M. Second, the Board suspended the quarterly cash dividend in mid-2026, preserving a small but real slice of annual cash. Third, the company refinanced its revolving credit facility with a related-party term loan, a tactical move that buys operating runway but locks in a higher interest cost and restricts future dividends.

The most important paragraph in the file is the going-concern disclosure itself. Management explicitly states that declining revenues, recurring operating losses, negative cash flows, and continued reduction in liquidity raise substantial doubt about the ability to continue as a going concern within one year of issuance. The 6-month operating loss of about $1.4M removes any clean read-through to a normalized run-rate. The second-quarter net loss of about $1.0M versus a year-earlier loss of about $0.4M shows deterioration rather than stabilization. The investment question is whether the cost base can be cut fast enough. Both are plausible but neither is yet visible in the numbers.